Profile of medication use during pregnancy: Results of the BRISA study, São Luís - MA, Brazil
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/24986 |
Resumo: | Objectives: To describe the medication profile used during pregnancy in a Brazilian capital. Methods: Descriptive cross-sectional study with data from BRISA study in São Luís, Maranhão. Participants were interviewed in hospitals and maternity hospitals after delivery and were asked about the use of medications during pregnancy. The drugs were classified according the Anatomical Therapeutic Chemical Classification and risk categories of the Food and Drug Administration. Results: 5,110 puerperal women were interviewed, of which 93.5% reported the use of at least one medication during pregnancy. The most frequent medications were: antianemic preparations (ferrous sulfate: 72.2%; iron and multivitamins: 4.9%, folic acid: 62.9% and associations with folic acid: 6.7%), vitamins (multivitamins and others minerals: 30.3%), analgesics (paracetamol: 12.3%), antibacterials for systemic use (cephalexin: 5.6%), antiemetics and anti-nauseating agents (scopolamine butylbromide: 5.4%) and antihypertensives (methyldopa): 3.6%). Among the drugs reported: 74.5% were from category A, 18.9% from category B, 5.5% from category C, 1.0% from category D and 0.1% from category X. Conclusions: Despite, the higher prevalence of medication use during pregnancy, most of which are considered safe in pregnancy. However, it is important that the use of drugs during pregnancy is monitored and guided by health professionals in order to ensure its rational use. |
id |
UNIFEI_8ca3aa37ddceceaf6799d37c20bbd23b |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/24986 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Profile of medication use during pregnancy: Results of the BRISA study, São Luís - MA, BrazilPerfil de uso de medicamentos durante el embarazo: Resultados del estudio BRISA, São Luís - MA, BrasilPerfil do uso de medicamentos durante a gestação: Resultados do estudo BRISA, São Luís - MA, BrasilPharmaceutical PreparationsPregnancyDescriptiveEpidemiologyPrevalence. MedicamentosGestaçãoEpidemiologiaEstudos descritivosPrevalência.Preparaciones farmacéuticas; El embarazo; Epidemiología, descriptiva, prevalenciaObjectives: To describe the medication profile used during pregnancy in a Brazilian capital. Methods: Descriptive cross-sectional study with data from BRISA study in São Luís, Maranhão. Participants were interviewed in hospitals and maternity hospitals after delivery and were asked about the use of medications during pregnancy. The drugs were classified according the Anatomical Therapeutic Chemical Classification and risk categories of the Food and Drug Administration. Results: 5,110 puerperal women were interviewed, of which 93.5% reported the use of at least one medication during pregnancy. The most frequent medications were: antianemic preparations (ferrous sulfate: 72.2%; iron and multivitamins: 4.9%, folic acid: 62.9% and associations with folic acid: 6.7%), vitamins (multivitamins and others minerals: 30.3%), analgesics (paracetamol: 12.3%), antibacterials for systemic use (cephalexin: 5.6%), antiemetics and anti-nauseating agents (scopolamine butylbromide: 5.4%) and antihypertensives (methyldopa): 3.6%). Among the drugs reported: 74.5% were from category A, 18.9% from category B, 5.5% from category C, 1.0% from category D and 0.1% from category X. Conclusions: Despite, the higher prevalence of medication use during pregnancy, most of which are considered safe in pregnancy. However, it is important that the use of drugs during pregnancy is monitored and guided by health professionals in order to ensure its rational use.Objetivos: Describir el perfil de medicación utilizada durante el embarazo en una capital brasileña. Métodos: Estudio descriptivo transversal con datos del estudio BRISA en São Luís, Maranhão. Las participantes fueron entrevistadas en hospitales y maternidades después del parto y se les preguntó sobre el uso de medicamentos durante el embarazo. Los medicamentos se clasificaron de acuerdo con la Clasificación Química Anatómica Terapéutica y las categorías de riesgo de la Administración de Alimentos y Medicamentos. Resultados: Se entrevistó a 5.110 puérperas, de las cuales el 93,5% refirió el uso de al menos un medicamento durante el embarazo. Los medicamentos más frecuentes fueron: preparados antianémicos (sulfato ferroso: 72,2%; hierro y multivitamínicos: 4,9%, ácido fólico: 62,9% y asociaciones con ácido fólico: 6,7%), vitaminas (multivitamínicos y otros minerales: 30,3%), analgésicos (paracetamol: 12,3%), antibacterianos de uso sistémico (cefalexina: 5,6%), antieméticos y antieméticos (butilbromuro de escopolamina: 5,4%) y antihipertensivos (metildopa): 3,6%). Entre los medicamentos reportados: 74,5% eran de la categoría A, 18,9% de la categoría B, 5,5% de la categoría C, 1,0% de la categoría D y 0,1% de la categoría X. Conclusiones: A pesar de la mayor prevalencia del uso de medicamentos durante el embarazo, la mayoría de los cuales se consideran seguros durante el embarazo. Sin embargo, es importante que el uso de medicamentos durante el embarazo sea monitoreado y guiado por profesionales de la salud para asegurar su uso racional.Objetivos: Descrever o perfil do uso de medicamentos na gestação em uma capital brasileira. Métodos: Estudo transversal descritivo com dados do estudo BRISA em São Luís, Maranhão. As participantes foram entrevistadas nos hospitais e maternidades após o parto, sendo questionadas sobre o uso de medicamentos na gestação. Os medicamentos foram classificados de acordo com a Anatomical Therapeutic Chemical Classification e categorias de risco da Food and Drug Administration. Resultados: Foram entrevistadas 5.110 puérperas, das quais 93,5% relataram o uso de pelo menos um medicamento na gestação. Os medicamentos mais frequentes foram: preparações antianêmicas (sulfato ferroso: 72,2%; ferro e multivitaminas: 4,9%, ácido fólico: 62,9% e associações com ácido fólico: 6,7%), vitaminas (multivitamínicos e outros minerais: 30,3%), analgésicos (paracetamol: 12,3%), antibacterianos de uso sistêmico (cefalexina: 5,6%), antieméticos e antinauseantes (butilbrometo de escopolamina: 5,4%) e anti-hipertensivos (metildopa: 3,6%). Dentre os medicamentos relatados: 74,5% foram da categoria A, 18,9% da categoria B, 5,5% da categoria C, 1,0% da categoria D e 0,1% da categoria X. Conclusões: Observou-se elevada prevalência de utilização de medicamentos na gestação, sendo a maioria de uso considerado seguro na gravidez. Porém, é importante que a utilização de fármacos na gestação seja monitorada e orientada por profissionais de saúde visando garantir o seu uso racional.Research, Society and Development2022-01-23info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/2498610.33448/rsd-v11i2.24986Research, Society and Development; Vol. 11 No. 2; e21811224986Research, Society and Development; Vol. 11 Núm. 2; e21811224986Research, Society and Development; v. 11 n. 2; e218112249862525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIenghttps://rsdjournal.org/index.php/rsd/article/view/24986/22482Copyright (c) 2022 Renata Monteiro Lima; Joseane Lima Prado Godinho; Elma Izze da Silva Magalhães; Anaximandro Braga Brito; Maria Helena Seabra Soares de Britto; Maria Teresa Seabra Soares de Britto e Alves; Alcione Miranda dos Santoshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessLima, Renata Monteiro Godinho, Joseane Lima Prado Magalhães, Elma Izze da Silva Brito, Anaximandro Braga Britto, Maria Helena Seabra Soares de Alves, Maria Teresa Seabra Soares de Britto e Santos, Alcione Miranda dos 2022-02-07T01:42:50Zoai:ojs.pkp.sfu.ca:article/24986Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:43:22.681884Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Profile of medication use during pregnancy: Results of the BRISA study, São Luís - MA, Brazil Perfil de uso de medicamentos durante el embarazo: Resultados del estudio BRISA, São Luís - MA, Brasil Perfil do uso de medicamentos durante a gestação: Resultados do estudo BRISA, São Luís - MA, Brasil |
title |
Profile of medication use during pregnancy: Results of the BRISA study, São Luís - MA, Brazil |
spellingShingle |
Profile of medication use during pregnancy: Results of the BRISA study, São Luís - MA, Brazil Lima, Renata Monteiro Pharmaceutical Preparations Pregnancy Descriptive Epidemiology Prevalence. Medicamentos Gestação Epidemiologia Estudos descritivos Prevalência. Preparaciones farmacéuticas; El embarazo; Epidemiología, descriptiva, prevalencia |
title_short |
Profile of medication use during pregnancy: Results of the BRISA study, São Luís - MA, Brazil |
title_full |
Profile of medication use during pregnancy: Results of the BRISA study, São Luís - MA, Brazil |
title_fullStr |
Profile of medication use during pregnancy: Results of the BRISA study, São Luís - MA, Brazil |
title_full_unstemmed |
Profile of medication use during pregnancy: Results of the BRISA study, São Luís - MA, Brazil |
title_sort |
Profile of medication use during pregnancy: Results of the BRISA study, São Luís - MA, Brazil |
author |
Lima, Renata Monteiro |
author_facet |
Lima, Renata Monteiro Godinho, Joseane Lima Prado Magalhães, Elma Izze da Silva Brito, Anaximandro Braga Britto, Maria Helena Seabra Soares de Alves, Maria Teresa Seabra Soares de Britto e Santos, Alcione Miranda dos |
author_role |
author |
author2 |
Godinho, Joseane Lima Prado Magalhães, Elma Izze da Silva Brito, Anaximandro Braga Britto, Maria Helena Seabra Soares de Alves, Maria Teresa Seabra Soares de Britto e Santos, Alcione Miranda dos |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Lima, Renata Monteiro Godinho, Joseane Lima Prado Magalhães, Elma Izze da Silva Brito, Anaximandro Braga Britto, Maria Helena Seabra Soares de Alves, Maria Teresa Seabra Soares de Britto e Santos, Alcione Miranda dos |
dc.subject.por.fl_str_mv |
Pharmaceutical Preparations Pregnancy Descriptive Epidemiology Prevalence. Medicamentos Gestação Epidemiologia Estudos descritivos Prevalência. Preparaciones farmacéuticas; El embarazo; Epidemiología, descriptiva, prevalencia |
topic |
Pharmaceutical Preparations Pregnancy Descriptive Epidemiology Prevalence. Medicamentos Gestação Epidemiologia Estudos descritivos Prevalência. Preparaciones farmacéuticas; El embarazo; Epidemiología, descriptiva, prevalencia |
description |
Objectives: To describe the medication profile used during pregnancy in a Brazilian capital. Methods: Descriptive cross-sectional study with data from BRISA study in São Luís, Maranhão. Participants were interviewed in hospitals and maternity hospitals after delivery and were asked about the use of medications during pregnancy. The drugs were classified according the Anatomical Therapeutic Chemical Classification and risk categories of the Food and Drug Administration. Results: 5,110 puerperal women were interviewed, of which 93.5% reported the use of at least one medication during pregnancy. The most frequent medications were: antianemic preparations (ferrous sulfate: 72.2%; iron and multivitamins: 4.9%, folic acid: 62.9% and associations with folic acid: 6.7%), vitamins (multivitamins and others minerals: 30.3%), analgesics (paracetamol: 12.3%), antibacterials for systemic use (cephalexin: 5.6%), antiemetics and anti-nauseating agents (scopolamine butylbromide: 5.4%) and antihypertensives (methyldopa): 3.6%). Among the drugs reported: 74.5% were from category A, 18.9% from category B, 5.5% from category C, 1.0% from category D and 0.1% from category X. Conclusions: Despite, the higher prevalence of medication use during pregnancy, most of which are considered safe in pregnancy. However, it is important that the use of drugs during pregnancy is monitored and guided by health professionals in order to ensure its rational use. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-01-23 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/24986 10.33448/rsd-v11i2.24986 |
url |
https://rsdjournal.org/index.php/rsd/article/view/24986 |
identifier_str_mv |
10.33448/rsd-v11i2.24986 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/24986/22482 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 11 No. 2; e21811224986 Research, Society and Development; Vol. 11 Núm. 2; e21811224986 Research, Society and Development; v. 11 n. 2; e21811224986 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052701674045440 |